Trial Profile

A Randomised, Double-blind, Multicenter, Parallel-group Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily With Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Subjects Stepped Down From a Maintenance Therapy With RELVAR Inhaler (FF/VI) 100/25 mcg Once-daily in Japanese Subjects

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 06 Sep 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Fluticasone furoate (Primary) ; Fluticasone propionate; Vilanterol/fluticasone furoate
Indications Asthma
Focus Registrational; Therapeutic Use
Sponsors GSK

18 Sep 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
05 Apr 2015 Planned End Date changed from 1 Oct 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.
05 Apr 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Aug 2015, as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com